Canada - National pharmacare to make prescription drugs more accessible and affordable ♦♦♦ US - Senate panel backs giving Florida access to Canadian drugs ♦♦♦ China - Reforms to drug approvals, monitoring and pricing to improve access


Shilling C, Incze A. Pricing & Access Trends for Biosimilars and Innovative Biologics in Europe. Business Development and Licensing Journal 2017 July ;25

Shilling C. Pricing, Reimbursement & Market Access: the biggest hurdle in life science innovation? - BioStars, January 2016

Amoaku W, Bishop P, Foss A, Hoad G, Johnston R, Luthert P, Shilling C, Smith J. Age-related macular degeneration: collaborating to find a cure. March 2016.

Incze A. Regulating Drug Prices: summary of presentation. Lorrach University. April 2016

Nagy B, Timár G, Józwiak-Hagymásy J, Kovács G, Merész G, Vámossy I, Ágh T, László Á, Vokó Z, Kaló Z. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:75-81

Incze A, Noehrenberg E. Pricing for gold in this multi-criteria multi-payer world. 4th Pricing & Profit Optimization Forum on Life Sciences - EPP Montreux, June 4-5, 2014

Kaló Z, Harsányi A, Vámossy I. Investment Aspects of Generic Drug Policies in Countries With Severe Resource Constraints. Value Health. 2014 Nov;17

Lorenzovici L, Székely A, Ágh T, Vámossy I, Kelemen LJ, Finta H, Kaló Z. Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania. Value Health. 2014 Nov;17

Incze A. Loss of exclusivity - still going profit-strong! How to make it happen? ! 3rd Pricing & Profit Optimization Forum on Life Sciences - EPP Montreux, June 5-6, 2013

Incze A. Pricing & Market Access Aspects to Consider During Development. World Biosimilar Conference, London September 2012

Incze A. Value Based Pricing: Key Aspects from a Different Perspective. 3rd Annual Payer Experiences Conference, Berlin June 2011

Thompson D, Campbell J, Parekh H, Vincze G, Incze A, Navarro J, Weinstein C M. Estimated Clinical and Economic Impact of Poor Patient Persistence with Osteoporosis Medications in Brazil. ISPOR LATAM Conference September 2009

Gabriela Tannus Branco de Araújo, Incze A. Comparison of Data Availability and Quality for Pharmacoeconomic Analyses in Brazil Versus The United States and European Union. ISPOR LATAM Conference Podium Presentation September 2009